Načítá se...
P17.34 CONCURRENT CHEMORADIOTHERAPY IN GLIOBLASTOMA MULTIFORME: RETROSPECTIVE STUDY
BACKGROUND: Concurrent radiotherapy with Temozolomide (TMZ) is the standard of care in management of Glioblastoma Multiforme (GBM) since it led to survival benefit over radiotherapy alone. On the basis of this evidence, we initiated this study. The aim of this work was to investigate the efficacy an...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185731/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.363 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|